Candriam S.C.A. Natera, Inc. Call Options Transaction History
Candriam S.C.A.
- $17.1 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding NTRA
# of Institutions
528Shares Held
119MCall Options Held
308KPut Options Held
191K-
Vanguard Group Inc Valley Forge, PA11.4MShares$1.95 Billion0.03% of portfolio
-
Black Rock Inc. New York, NY6.77MShares$1.16 Billion0.02% of portfolio
-
Jpmorgan Chase & CO New York, NY4.63MShares$791 Million0.05% of portfolio
-
Farallon Capital Management LLC San Francisco, CA4.56MShares$778 Million2.91% of portfolio
-
Fred Alger Management, LLC New York, NY4.01MShares$685 Million2.57% of portfolio
About Natera, Inc.
- Ticker NTRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 96,957,400
- Market Cap $16.6B
- Description
- Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...